buserelin has been researched along with Adenoma, Prostatic in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (58.33) | 18.7374 |
1990's | 4 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Attard, S; Ferré-Dolcet, L; Pisu, MC; Romagnoli, S | 1 |
Bélanger, A; Dubé, JY; Frenette, G; Tremblay, RR; Tremblay, Y | 1 |
Bélanger, A; Dubé, JY; Frenette, G; Labrie, F; Tremblay, RR; Tremblay, Y | 1 |
Schröder, FH | 1 |
Lukkarinen, O | 1 |
Forti, G; Serio, M | 1 |
Schmidt, JD | 1 |
Bosch, RJ; Kurth, KH; Schroeder, FH; Westerhof, M | 1 |
Keane, PF; Kiely, E; Stamp, G; Timoney, AG; Williams, G | 1 |
Asano, M; Fujita, K; Isurugi, K; Kawabe, K; Kinoshita, K; Nakauchi, K; Niijima, T; Nishimura, Y; Nitoh, H; Yokoyama, M | 1 |
Blom, JH; Bosch, RJ; Griffiths, DJ; Schroeder, FH | 1 |
Costantini, A; De Bellis, A; Fiorelli, G; Longo, A; Natali, A; Serio, M | 1 |
1 review(s) available for buserelin and Adenoma, Prostatic
Article | Year |
---|---|
Medical treatment of benign prostatic hyperplasia: the effect of surgical or medical castration.
Topics: Buserelin; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prostate; Prostatic Hyperplasia | 1994 |
1 trial(s) available for buserelin and Adenoma, Prostatic
Article | Year |
---|---|
Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters.
Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Humans; Male; Prospective Studies; Prostate; Prostatic Hyperplasia; Random Allocation; Ultrasonography; Urodynamics | 1989 |
10 other study(ies) available for buserelin and Adenoma, Prostatic
Article | Year |
---|---|
Effect of the GnRH stimulation test on Canine Prostatic-Specific Esterase (CPSE).
Topics: Animals; Buserelin; Dog Diseases; Dogs; Esterases; Male; Prostate; Prostatic Hyperplasia; Semen Analysis; Testosterone | 2023 |
Involution of spontaneous benign prostatic hyperplasia in the dog under the influence of chronic treatment with a LHRH agonist.
Topics: Animals; Buserelin; Castration; Cytosol; Dogs; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Testis | 1984 |
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Buserelin; Castration; Dihydrotestosterone; Dogs; Estrogens; Hydroxyprogesterones; Male; Progesterone; Prostatic Hyperplasia; Testis; Testosterone | 1984 |
Effect of LH-RH analogue in patients with benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Buserelin; Goserelin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Ultrasonography; Urinary Retention | 1991 |
[Gn-RH analogs and benign prostatic hypertrophy].
Topics: Antineoplastic Agents; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Prostatic Hyperplasia | 1990 |
Medical treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Androstenes; Azasteroids; Buserelin; Finasteride; Goserelin; Humans; Leuprolide; Male; Prostatic Hyperplasia | 1991 |
Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases.
Topics: Aged; Aged, 80 and over; Buserelin; Humans; Male; Middle Aged; Orchiectomy; Prostatic Hyperplasia; Urination Disorders | 1986 |
Response of the benign hypertrophied prostate to treatment with an LHRH analogue.
Topics: Buserelin; Castration; Gonadal Steroid Hormones; Humans; Male; Prostatic Hyperplasia; Urinary Bladder Neck Obstruction; Urination | 1988 |
[Clinical experience with single and multiple subcutaneous administration of LHRH analog Buserelin (Hoe 766) in prostatic carcinoma: endocrinological study of optimum subcutaneous doses].
Topics: Aged; Aged, 80 and over; Buserelin; Drug Evaluation; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Prognosis; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Thyrotropin | 1988 |
Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
Topics: Aged; Binding Sites; Buserelin; Dihydrotestosterone; Epidermal Growth Factor; ErbB Receptors; Goserelin; Humans; Male; Middle Aged; Models, Biological; Prostatic Hyperplasia; Testosterone | 1989 |